0001995074-26-000002.txt : 20260318 0001995074-26-000002.hdr.sgml : 20260318 20260318095717 ACCESSION NUMBER: 0001995074-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260318 DATE AS OF CHANGE: 20260318 EFFECTIVENESS DATE: 20260318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NurExone Biologic Inc. CENTRAL INDEX KEY: 0001995074 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576876 FILM NUMBER: 26766399 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B STREET 2: GUTWIRTH INDUSTRIAL PARK CITY: TECHNION CITY, HAIFA PROVINCE COUNTRY: L3 BUSINESS PHONE: 972 52-4803034 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B STREET 2: GUTWIRTH INDUSTRIAL PARK CITY: TECHNION CITY, HAIFA PROVINCE COUNTRY: L3 D 1 primary_doc.xml X0708 D LIVE 0001995074 NurExone Biologic Inc. MINUS 1 ENTRY, GROUND FLOOR OF BLDG B GUTWIRTH INDUSTRIAL PARK TECHNION CITY, HAIFA L3 ISRAEL 3200003 972 52-4803034 ONTARIO, CANADA WALMER CAPITAL CORP. ENERSPAR CORP. None Corporation true 2025 Lior Shaltiel Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Director Eran Ovadya Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Yoram Drucker Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Director Oded Orgil Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director James Richardson Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director Eyal Gabbai Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director Biotechnology Decline to Disclose 06b false 2026-03-10 false true true true false 0 279910 279910 0 CDN$379,745. Based on the Bank of Canada exchange rate of 0.7371 on March 10, 2026. Consists of the issuance of 558,449 units. false 4 0 0 0 false NurExone Biologic Inc. /s/Eran Ovadya Eran Ovadya Chief Financial Officer 2026-03-18